The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes
Source: Eur Respir Mon; 2009: 46: 47–66
Disease area: Interstitial lung diseases
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: